Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CBL Antikörper (AA 556-906) (HRP)

Dieser Kaninchen Polyklonal Antikörper detektiert spezifisch CBL in WB, IHC und ELISA. Es zeigt Reaktivität gegenüber Proben von Human, Maus und Ratte.
Produktnummer ABIN7975080
720,50 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 8 bis 12 Werktagen

Kurzübersicht für CBL Antikörper (AA 556-906) (HRP) (ABIN7975080)

Target

Alle CBL Antikörper anzeigen
CBL (Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence (CBL))

Reaktivität

  • 208
  • 91
  • 88
  • 3
  • 2
  • 1
  • 1
  • 1
Human, Maus, Ratte

Wirt

  • 183
  • 23
  • 3
Kaninchen

Klonalität

  • 170
  • 39
Polyklonal

Konjugat

  • 86
  • 11
  • 9
  • 8
  • 7
  • 6
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
Dieser CBL Antikörper ist konjugiert mit HRP

Applikation

  • 110
  • 58
  • 55
  • 52
  • 52
  • 35
  • 32
  • 19
  • 14
  • 12
  • 12
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA
  • Bindungsspezifität

    • 36
    • 30
    • 20
    • 18
    • 17
    • 13
    • 11
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 556-906

    Verwendungszweck

    Anti-CBL Antibody HRP Conjugated

    Spezifität

    No cross reactivity with other proteins.

    Kreuzreaktivität (Details)

    No cross-reactivity with other proteins

    Homologie

    Human CBL shares 84% amino acid (aa) sequence identity with mouse CBL.

    Aufreinigung

    Immunogen affinity purified.

    Immunogen

    E.coli-derived human CBL recombinant protein (Position: A556-T906). Human CBL shares 84% amino acid (aa) sequence identity with mouse CBL.

    Isotyp

    IgG
  • Applikationshinweise

    Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    At -20°C for one year from date of receipt. Avoid repeated freezing and thawing.

    Haltbarkeit

    12 months
  • Target

    CBL (Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence (CBL))

    Andere Bezeichnung

    CBL

    Hintergrund

    Background: CBL (Cbl proto-oncogene) is also known as C-CBL, RNF55, CBL2 and E3 ubiquitin protein ligase. CBL is mapped to chromosome 11q23.3-qter by molecular characterization of the breakpoints in 2 somatic cell hybrids. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia. Mutations in this gene are also the cause of Noonan syndrome-like disorder.

    Gene Full Name: Cbl proto-oncogene

    Sequence Similarities: Contains 1 Cbl-PTB (Cbl-type phosphotyrosine-binding) domain.

    Gen-ID

    867

    UniProt

    P22681

    Pathways

    T-Zell Rezeptor Signalweg, Interferon-gamma Pathway, EGFR Signaling Pathway, EGFR Downregulation, VEGFR1 Specific Signals
Sie sind hier:
Chat with us!